Difficulty: Medium
Average Score: 93%
Practice
Indicate the hypnotic drug, which does not have active metabolites:
Correct answer
A
Rationale
In the context of pharmacological lifespan treatment, understanding the properties of hypnotic drugs is crucial. In this question, the correct answer is A) Zolpidem because it is a short-acting hypnotic drug that does not form active metabolites. Zolpidem is metabolized primarily by the liver and excreted through the kidneys without significant metabolism to active compounds.
Option B) Flurazepam is incorrect because it is a long-acting benzodiazepine derivative that undergoes significant metabolism to active metabolites, contributing to its prolonged effects.
Option C) Diazepam is also incorrect as it is a benzodiazepine with active metabolites that can accumulate in the body, leading to prolonged sedative effects and potential drug interactions.
Option D) Phenobarbital is incorrect because it is a barbiturate that undergoes metabolism to active compounds which can accumulate in the body with prolonged use, leading to tolerance and dependence issues.
Educationally, this question highlights the importance of considering the pharmacokinetic properties of drugs when selecting appropriate treatments, especially in vulnerable populations like different age groups across the lifespan. Understanding the differences in metabolism and active metabolites can help healthcare providers make informed decisions to optimize drug therapy and minimize potential risks of adverse effects or drug interactions.
Option B) Flurazepam is incorrect because it is a long-acting benzodiazepine derivative that undergoes significant metabolism to active metabolites, contributing to its prolonged effects.
Option C) Diazepam is also incorrect as it is a benzodiazepine with active metabolites that can accumulate in the body, leading to prolonged sedative effects and potential drug interactions.
Option D) Phenobarbital is incorrect because it is a barbiturate that undergoes metabolism to active compounds which can accumulate in the body with prolonged use, leading to tolerance and dependence issues.
Educationally, this question highlights the importance of considering the pharmacokinetic properties of drugs when selecting appropriate treatments, especially in vulnerable populations like different age groups across the lifespan. Understanding the differences in metabolism and active metabolites can help healthcare providers make informed decisions to optimize drug therapy and minimize potential risks of adverse effects or drug interactions.